Groups of children (mean age, 31.4 months) with Haemophilus influenzae type b meningitis, epiglottitis, or septic arthritis were tested for the presence and levels of bacteremia, capsular polyribophosphate (PRP) antigenemia, and development of specific antibody in serum after the onset of acute illness. Although bacteremia cleared promptly after antibiotic therapy, circulating PRP could be detected in serum for relatively long periods, with 51% of the patients still having detectable antigen after 30 days postinfection. Even in the presence of specific antibody, antigenemia persisted for as long as 47 days after admission. It was observed that there was no statistically significant correlation between the persistence of antigenemia and age (P > 0.2), the initial antigen concentration (P > 0.50), or the development of antibody (P > 0.20). The presence of a low magnitude of bacteremia (<300 organisms per ml) was associated with a maximum concentration of 10 ng of PRP per ml. On the other hand, bacterial counts in excess of 104/ml were associated with >1,000 ng of PRP per ml (r = q.98, r2 = 0.96, P < 0.001). It was observed that the amount of circulating PRP in the acute phase of ilness wa, related to whether a child developed convalescent-phase antibody. Invariably, the younger children, who primarily had meningitis, had a PRP concentration of >10 ng/ml and failed to develop an antibody response in any isotype, whereas the older patients, who primarily had infections other than meningitis, had a PRP concentration of <10 ng/ml and a 45.5% suctess rate in developing an antibody response (P = 0.006). These findings suggest that there is a direct correlation between the magnitudes of bacteremia and antigenemia, that antigen may persist for long periods even in the presence of, antibody, and that the level of antigenemia in addition to the patient age is significantly related to the nature of the convalescent-phase antibody response.
of ilness wa, related to whether a child developed convalescent-phase antibody. Invariably, the younger children, who primarily had meningitis, had a PRP concentration of >10 ng/ml and failed to develop an antibody response in any isotype, whereas the older patients, who primarily had infections other than meningitis, had a PRP concentration of <10 ng/ml and a 45.5% suctess rate in developing an antibody response (P = 0.006). These findings suggest that there is a direct correlation between the magnitudes of bacteremia and antigenemia, that antigen may persist for long periods even in the presence of, antibody, and that the level of antigenemia in addition to the patient age is significantly related to the nature of the convalescent-phase antibody response.
Haemophilus influenzae type b is the etiological agent of a wide spectrum of infections in children, yielding a significant degree of morbidity and mortality (2, 15) . Limited information is available on the amount of capsular material (polymer of ribose, ribitol, and phosphate, or polyribophosphate [PRP] antigen) detected in patients' body fluids and the quantitative relationship to the number of organisms present. Furthermore, little is known about the persistence of this antigen in serum and its effect on the development of antibody in children. In the present study, the concentrations of PRP and viable bacteria were determined in the blood of patients with H. influenzae type b infections during the acute phase of illness, and the persistence of PRP from the time of admission to the last positive result was monitored. In addition, the antibody response was determined during both the acute and convalescent phases of illness.
MATERIALS AND METHODS
Study population and specimen processing. The patient population comprised 18 children, io males and 8 females, admitted during a 24-month period to The Children's Hospital of Buffalo with acute H. influenzae type b infections. It included 11 patients with meningitis, 5 with epiglottitis, and 2 with septic arthritis. The age of the patients at the onset of illness ranged from 5 months to 7.5 years, with a mean age of 31.4 months. The objectives and risks of the study were explained to the parents, and a signed statement of informed consent was obtained.
For all study patients, samples of blood were initially collected before the administration of antibiotic therapy, usually on the day of admission. Subsequent blood samples were collected up to day 89 postadmission. Serum was separated by centrifugation and stored at -20°C until tested. Blood cultures were processed as previously described (6) (7) (8) . In brief, the blood was inoculated into both BACTEC aerobic bottles and sterile heparinized tubes for quantitative direct plating. A total of 1 to 3 ml of blood was inoculated into the bottles, and 0.1 to been previously described (6) . The identification of all isolates was performed by conventional procedures.
H. influenzae type b capsular antigen assay. PRP was detected and quantitated by an indirect enzyme-linked immunosorbent assay as previously described (11) .
Serum antibody assay. The class-specific antibody responses in serum to H. influenzae type b were determined in 18 patients by a previously described enzyme-linked immunosorbent assay (11) .
Statistical analysis. The relationship of the number of organisms per milliliter of blood to the serum antigen concentration was determined by using the Student t test after logarithmic transformation of the data. Correlation coefficients were determined for the persistence of serum PRP in relation to age, acute-phase antigen concentration, and convalescent-phase antibody. The (Fig. 2) .
Relationship of acute-phase PRP concentration in serum to convalescent-phase antibody response. The serum PRP antigen concentration in the acute phase of illness was correlated with the development of a convalescent-phase antibody response in all isotypes (Table 2) . Of the 18 children in the study, 11 had acute-phase serum PRP concentrations of <10 ng/ml (range, 0.13 to 7.5 ng/ml), and 7 had antigen concentrations of >10 ng/ml (range, 146 to 13,847 ng/ml). A significant correlation existed for 5 of the 11 (45.5%) children with acute-phase PRP concentrations of <10 ng/ml, who developed a convalescent-phase antibody response in all isotypes, in striking contrast to those patients with PRP concentrations of >10 ng/ml, who did not develop antibody in convalescence (P = 0.006) ( (3), indicate that the persistence of antigen, often in high concentrations, is common. Furthermore, all patients in the present study recovered in the expected time periods, with no serious sequelae. The persistence of circulating PRP should not necessarily be interpreted as evidence of antimicrobial failure, since all blood cultures from our patients became negative shortly after the administration of antibiotics. An observation of particular importance in this study was nzae, Streptococcus pneuthat the amount of circuilating PRP in the acute phase of and Escherichia coli attest illness correlated with the development of convalescentof antigen correlates with phase antibody. Invariably, the younger children, who pri-O, 12). Related to this, a marily had meningitis, had a PRP concentration of >10 ng/ml and failed to develop an antibody response in all isotypes, whereas the older patients, who primarily had infections other than meningitis, had a PRP concentration of <10 ng/ml and a 45.5% success rate in developing an antibody response. This observation is further supported by the results of O'Reilly et al. (9) indicating that antibody responses to H. influenzae uniformly were of a low magnitude in patients with prolonged antigenemia, irrespective of age. Furthermore, the results of another study (8a) Another interesting observation in this study was that essentially 1.0 to 10.0 ng of PRP antigen per ml detected by the enzyme-linked immunosorbent assay correlated with an upper limit of 300 cells and a lower limit of 14 cells. PRP concentrations of >1,000 ng/ml represented bacterial cell counts in excess of 104/ml. The variance in this relationship could be due to the fact that antigen detection measures both viable and nonviable cells, in contrast to just assaying CFU per milliliter. Furthermore, another factor could be strain variability in the amount of capsular material per cell. This degree of sensitivity of the enzyme-linked immunosorbent assay, in comparison with the results of previous reports (6, 13, 14) , is much higher than that of counterimmunoelectrophoresis, microscopy, Gram staining, or acridine orange staining but similar to that of latex agglutination.
In conclusion, for children having H. influenzae type b infections, there is a direct correlation between the magnitude of bacteremia and that of antigenemia, and both of these factors, in addition to the age of the child, may play a role in whether a child will develop antibody during convalescence.
